MustGrow Biologics Completes Acquisition of NexusBioAg

Share This Article
MustGrow Biologics Corp. is pleased to announce the execution and closing of an Asset Purchase Agreement (APA) with Univar Solutions Canada Ltd. for the acquisition of certain assets that represent NexusBioAg. The agreement, dated December 31, 2024, marks a strategic move to strengthen MustGrow’s position as a leading provider of biological and regenerative agriculture solutions.

The acquisition of NexusBioAg enables MustGrow to become a fully integrated provider, combining its innovative biological technologies with established sales, marketing, and distribution operations in Canada. This integration not only solidifies the Company’s presence in Canada but also presents opportunities to expand operations into the U.S. market, enhancing MustGrow’s ability to deliver sustainable agriculture solutions on a broader scale.

As per the terms of the APA, MustGrow will pay Univar Solutions a deferred cash payment of approximately $1,662,000.00, subject to adjustment, along with earn-out payments. The earn-out payments will be calculated as a specified percentage of the gross margin on certain itemized products sold by MustGrow in 2025 and 2026. The agreement is structured at arm’s length, and no finder fees are associated with the transaction.

The acquisition has been conditionally approved by the TSX Venture Exchange, subject to customary post-closing requirements. This strategic step aligns with MustGrow’s mission to revolutionize agriculture with innovative, sustainable solutions while strengthening its presence in North America’s biological agriculture market.

With this acquisition, MustGrow is set to advance its leadership in regenerative agriculture, providing farmers with cutting-edge tools to improve productivity while prioritizing environmental stewardship.

Source- Mustgrow